Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
Richard I. Horowitz, Phyllis R. Freeman
Medical Hypotheses (2020) Vol. 143, pp. 109851-109851
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Overview of the possible role of vitamin C in management of COVID-19
Anis Abobaker, Aboubaker Alzwi, Alsalheen Hamed A. Alraied
Pharmacological Reports (2020) Vol. 72, Iss. 6, pp. 1517-1528
Open Access | Times Cited: 148
Curcumin, a traditional spice component, can hold the promise against COVID-19?
Vivek Kumar Soni, Arundhati Mehta, Yashwant Kumar Ratre, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173551-173551
Open Access | Times Cited: 113
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
Jean Bousquet, Josep M. Anto, Heather J. Zar, et al.
Allergy (2020) Vol. 76, Iss. 3, pp. 735-750
Open Access | Times Cited: 112
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 97
COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 96
Potential of Sulforaphane as a Natural Immune System Enhancer: A Review
Andrea Mahn, Antonio Castillo
Molecules (2021) Vol. 26, Iss. 3, pp. 752-752
Open Access | Times Cited: 81
Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients
Mohsen Karami Fath, Malihe Naderi, Hosna Hamzavi, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 73, pp. 127044-127044
Open Access | Times Cited: 39
Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review
Elizabeth Houlding, Kedar Mate, Kim Engler, et al.
JMIR mhealth and uhealth (2021) Vol. 9, Iss. 4, pp. e24743-e24743
Open Access | Times Cited: 50
Repurposing existing drugs for COVID-19: an endocrinology perspective
Flavio Cadegiani
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Substantial changes in gaseous pollutants and chemical compositions in fine particles in the North China Plain during the COVID-19 lockdown period: anthropogenic vs. meteorological influences
Rui Li, Yilong Zhao, Hongbo Fu, et al.
Atmospheric chemistry and physics (2021) Vol. 21, Iss. 11, pp. 8677-8692
Open Access | Times Cited: 37
Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature
Giuseppe Fabio Parisi, Giuseppe Carota, Carlo Castruccio Castracani, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2465-2465
Open Access | Times Cited: 36
Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19
Éric Azabou, Guillaume Bao, Rania Bounab, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 35
Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD)
Yuanzhou He, Min Xie, Jianping Zhao, et al.
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 33
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases
Jean Bousquet, Vincent Le Moing, Hubert Blain, et al.
World Allergy Organization Journal (2020) Vol. 14, Iss. 1, pp. 100498-100498
Open Access | Times Cited: 33
Immunopharmacological perspective on zinc in SARS-CoV-2 infection
Sima Heydarzadeh Asl, Sepideh Nikfarjam, Naime Majidi Zolbanin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107630-107630
Open Access | Times Cited: 30
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
Heidi N. du Preez, Colleen Aldous, Hendrik G. Kruger, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 21
Glucosinolates and their hydrolysis products as potential nutraceuticals to combat cytokine storm in SARS-COV-2
Saba Rahimi Bahoosh, Yalda Shokoohinia, Mahdieh Eftekhari
DARU Journal of Pharmaceutical Sciences (2022) Vol. 30, Iss. 1, pp. 245-252
Open Access | Times Cited: 19
Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?
Bhavdeep Singh, Eli Eshaghian, Judith Chuang, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1909-1909
Open Access | Times Cited: 19
The Antiaging Effect of Active Fractions and Ent-11α-Hydroxy-15-Oxo-Kaur-16-En-19-Oic Acid Isolated from Adenostemma lavenia (L.) O. Kuntze at the Cellular Level
Irmanida Batubara, Rika Indri Astuti, Muhammad Eka Prastya, et al.
Antioxidants (2020) Vol. 9, Iss. 8, pp. 719-719
Open Access | Times Cited: 24
Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations
Jacek Haneczok, Marcin Delijewski
Journal of Biomedical Informatics (2021) Vol. 119, pp. 103821-103821
Open Access | Times Cited: 23
Mathematical analysis of the dynamics of COVID‐19 in Africa under the influence of asymptomatic cases and re‐infection
Abayomi Samuel Oke, Oluwafemi Isaac Bada, Ganiyu Rasaq, et al.
Mathematical Methods in the Applied Sciences (2021) Vol. 45, Iss. 1, pp. 137-149
Open Access | Times Cited: 20
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19
Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth
Yaw‐Syan Fu, Wan‐Yi Ho, Ning Kang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Yifan Wang, Jing Ma, Yongfang Jiang
Cell Stress and Chaperones (2022) Vol. 28, Iss. 1, pp. 11-20
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top